White House Releases National Drug Control Strategy January 31, 2019 Today, Jim Carroll, the newly sworn-in Director of the White House Office of National Drug Control Policy (ONDCP), released the Administration’s National Drug Control Strategy, which establishes the President’s priorities for addressing the challenge of drug trafficking and use. “Our number one goal is to save […]
Prevention
D.C. announces plan to cut opioid-related deaths by half
From the Washington Post. In long-awaited plan, D.C. aims to reduce opioid deaths by half by late 2020 by Jenna Portnoy The District on Monday announced a plan aimed at cutting opioid-related deaths by half over the next 21 months, using a long list of treatment, tracking and education initiatives. Start-up costs of $24 million will […]
2nd Needle Exchange Program Opens in Richmond
From the Richmond Times-Dispatch. Second needle exchange program launches at Richmond free clinic with RPD support by Bridget Balch Virginia’s second needle exchange program — an initiative aimed at reducing the risk of spreading bloodborne disease by offering clean needles to injection drug users — was launched in Richmond this week. The Health Brigade, formerly […]
September 2018 Dialogue eNewsletter now available
Read inspirational, personal recovery stories and get all the information you need for National Recovery Month.
Tech Takes on Cigarette Smoking
From ScienceDaily Researchers develop system that senses smoking movements, sends motivational text messages, videos to help users quit smoking Researchers at Case Western Reserve University are using wearable sensor technology to develop an automatic alert system to help people quit smoking. The smart-phone app, initially limited to android-based operating systems, automatically texts 20- to […]
DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore
DOTS Bulletin. June 2018. Issue 2.
Naloxone Recall—Two Lots From Hospira Recalled Due to Particulate Matter
Recall from the FDA Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System due to the Potential Presence of Particulate Matter Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, […]